bioMérieux S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 1,658 million compared to EUR 1,574.2 million a year ago. Net income was EUR 228 million compared to EUR 277.1 million a year ago.

Basic earnings per share from continuing operations was EUR 1.93 compared to EUR 2.34 a year ago. Diluted earnings per share from continuing operations was EUR 1.93 compared to EUR 2.33 a year ago.